Glioblastoma

Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma

Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma

Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations

A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

Methimazole in Patients With Progressive Glioblastoma

Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma

Surgical Pembro +/- Olaparib w TMZ for rGBM

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma.

A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression

Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study

Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

A Clinical Trial of P134 Cells in Recurrent Glioblastoma

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Chemoradiotherapy Versus Chemotherapy for Elderly and Frail GBM Patients

Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma

The GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma

A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma

A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

A Study Evaluating Temferon in Patients With Glioblastoma & Unmethylated MGMT

Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma

Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)

5G-PEARL: Paxalisib in Malignant Brain Tumours

Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma

Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma

Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)

Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma

Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study

Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study

Surgery for Recurrent Glioblastoma

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Venous Thromboembolism Prevention in Outpatients With Glioma

ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids

A Clinical Trial Testing the Safety of BNT327 (an Investigational Drug) and How Well it Works in Patients With Recurrent Glioblastoma

INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)

Early Phase Study of Kesonotide in Participants With Solid Tumours

Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma

A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)

Irinotecan-ChemoSeed in Surgically Resectable Glioblastoma

Effect of Salovum® on Pressure, Oxygen and Inflammation in Glioblastoma

Study of Pembrolizumab and M032 (NSC 733972)

5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours

Evaluation of UCPVax Vaccine +/- Pembrolizumab Combined With Standard Treatment as Adjuvant Therapy in Patients With Unmethylated MGMT Glioblastoma

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)

Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma

Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab

Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma

Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)

Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG

Niraparib/TTFields in GBM

Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma

OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial

Newly Diagnosed Glioblastoma

A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma

WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma

A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment

Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients

Clinical Study of Oncolytic Virus in Glioblastoma

A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging

Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma

Vortioxetine for Newly Diagnosed Glioblastoma

A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme

Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age

Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype

Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide

A Phase I/II Clinical Trial on the Per-operative Intratumoral Administration of Myeloid Dendritic Cells Plus Ipilimumab and Nivolumab, Followed by Repeated Intracavitary Plus Intravenous Administration of Nivolumab in Patients With Recurrent Glioblastoma.

hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)

A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)

A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial

NG101m Adjuvant Therapy in Glioblastoma Patients

Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma

Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM

Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells

D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients

Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma

Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab

Pharmacoscopy for Patients With Refractory Primary Brain Tumors

Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread

G-CSF After Chemo-radiation in Patients With Glioblastoma

Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: A Phase 2 Hybrid Randomized Trial

DLL3 CAR-T Therapy Targeting Brain Tumors

Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow

A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma

A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma

Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma

A Study of Abemaciclib in Recurrent Glioblastoma

DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma

Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)

Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma

ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma Multiforme

Phase 2 Clinical Trial of KH617

Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma

Clinical Study on the Treatment of Malignant Brain Glioma by QH104 Cell Injection

Sonodynamic-Chemoradiotherapy Integration in Glioblastoma

Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma

Lerapolturev (PVSRIPO) in GBM

Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma

Pembrolizumab in Treating Patients With Recurrent Glioblastoma

A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas

IA Carboplatin + Radiotherapy in Relapsing GBM

Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields

Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma

Sacituzumab Govitecan in Recurrent Glioblastoma

Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma

Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma

Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma

Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases

Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma

A Phase II Clinical Study to Evaluate the Efficacy and Safety of Flazoparib Combined With Temozolomide After the Completion of Standard Concurrent Chemoradiotherapy (CCRT) in Newly Diagnosed Glioblastoma

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM

Tamoxifen Versus Etoposide After First Recurrence in GBM Patients

Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients

Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma

Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform

Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme

A Trial of Ipatasertib in Combination With Atezolizumab

PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma

A Study of BL-B01D1 in Patients With Recurrent Glioblastoma

A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme

A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma

Enhanced Adjuvant Therapy for Newly Diagnosed GBM With Partial Surgical Resection or Short-term Progression

Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma

DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab

A Study of Chlorophyllin for the Management of Brain Radio-necrosis in Patients With Diffuse Glioma

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas

Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature

Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma

Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors

Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects

Study of LP-184 in Patients With Advanced Solid Tumors

Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM

Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma

AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma

Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema

A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence

Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After Surgery

Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor

Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM

Efficiency of Vaccination with Lysate-loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma

UNITy-BasED MR-Linac Adaptive Simultaneous Integrated Hypofractionated Boost Trial for High Grade Glioma in the Elderly

Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas

HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma

TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas

Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

Evaluate the Efficacy and Safety of ADCV01 As an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients

Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients

JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)

Azeliragon in MGMT Unmethylated Glioblastoma

TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.

T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma

Glutamate Inhibitors in Glioblastoma

Pembrolizumab for Newly Diagnosed Glioblastoma

A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT)

A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression

Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)

Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma

Evaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM).

The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma

The Effectiveness of HP and TMZ Synergism on Adult Recurrence GBM

B-amyloid as a Marker for GBM Bioimaging

Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma

Tislelizumab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for Bevacizumab Refractory Recurrent Glioblastoma

Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed Glioblastoma

Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNA-level-relapse and Clinical-relapse Glioblastoma

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma

TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma

HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy

Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM

Study of Niacin in Glioblastoma

Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations

Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma

Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter

Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma

First-in-Human, Phase 1b/2a Trial of a Multipeptide Therapeutic Vaccine in Patients With Progressive Glioblastoma

Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)

Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma

Neoadjuvant Chemoradiation for Resectable Glioblastoma

Assessment of Novel Metabolic Imaging Modalities as A Predictor Of Therapeutic EfficacyiIn Glioblastoma (GBM)

Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma

CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial

11C-methionine in Diagnostics and Management of Glioblastoma Multiforme Patients (GlioMET)

Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma

Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression

Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting

Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

PriCoTTF Study: TTFields Before and During Radiotherapy for Newly Diagnosed Glioblastoma

Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma

Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab

Abemaciclib + Pembrolizumab In Glioblastoma

Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)

Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors

18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy

Temozolomide Chronotherapy for High Grade Glioma

Talazoparib - Carboplatin for Recurrent High-grade Glioma With DDRd

VB-111 in Surgically Accessible Recurrent/Progressive GBM

Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001

Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma

A Study Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and Durvalumab for Patients With Recurrent Glioblastoma

LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma

Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme

PARP Inhibition for Gliomas (PI-4G or π4g)

Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma

Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma

Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma

Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma

A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients

Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms

Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma

Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma

Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas

Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme

BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations

Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma

Testing the Combination of Anti-cancer Drugs Tiragolumab and Atezolizumab to Improve Outcomes for Patients With Recurrent Glioblastoma

Oral ONC201 in Adult Recurrent Glioblastoma

A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma

Lenvatinib, Pembrolizumab, and Tumor Treating Fields (TTFields) for Second-line Treatment of Glioblastoma

Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Opening Using Exablate MRI-guided Focused Ultrasound (Exablate MRgFUS) for Recurrent Glioblastoma

Sonodynamic Therapy with ExAblate System in Glioblastoma Patients

18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma

Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors

Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG

Combined Treatment of Camrelizumab and Bevacizumab for Adult Patients with Recurrent Glioblastoma (GBM)

Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme

Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG

Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma

A Phase I/IIa Study of Cerebraca Wafer Plus Adjuvant Temozolomide (TMZ) in Patients With Recurrent High Grade Glioma

Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence

Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma

Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM

A Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Subjects With Recurrent GBM

Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)

Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma

A Trial of Neoadjuvant Therapy in Patients With Newly Diagnosed Glioblastoma

Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab

Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma

Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma

Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors

A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma

Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma

A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation

The Addition of Chloroquine to Chemoradiation for Glioblastoma,

A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma

Nab-sirolimus in Recurrent High Grade Glioma and Newly Diagnosed Glioblastoma

NCT Neuro Master Match - N²M² (NOA-20)

Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma

A Trial of One-week on/One-week Off Temozolomide Versus Continuous Dose-Intense Temozolomide in Patients With Glioblastoma Multiforme at First Relapse

Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma

DC Migration Study for Newly-Diagnosed GBM

Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Glioblastoma

GC1118 in Recurrent Glioblastoma Patients With High EGFR Amplification

131I-IPA and Concurrent XRT in Recurrent GBM

CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type

Trial of Combination Tumor Treating Fields (TTF; Optune), Nivolumab Plus/Minus Ipilimumab for Recurrent Glioblastoma

Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients

Evaluation of GLR2007 for Advanced Solid Tumors

BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma

Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma

Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma

Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants

Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children

Regorafenib in Relapsed Glioblastoma

Safety and Efficacy of Transient Opening of the Blood-brain Barrier (BBB) With the SonoCloud-9

TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab

Laser Interstitial Thermal Therapy and Lomustine in Treating Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma

Nivolumab, Ipilimumab, and Short-course Radiotherapy in Adults With Newly Diagnosed, MGMT Unmethylated Glioblastoma

Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma

TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma

Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab

HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma

Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma

A Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas

Efficacy and Safety Study of GX-I7 Plus Adjuvant Temozolomide Combination in Patients With Newly Diagnosed Glioblastoma

A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma

Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma

TMS Electrochemotherapy for Glioblastoma Multiforme

Safety, Tolerability and Efficacy of Disulfiram and Copper Gluconate in Recurrent Glioblastoma

Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma

Phase 1/2 Study of USL311 +/- Lomustine in Advanced Solid Tumors or Relapsed/Recurrent Glioblastoma Multiforme (GBM)

Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects

Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma

Antisecretory Factor in Primary Glioblastoma 1

Prolonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine Glioma

Trial to Evaluate the Safety of TTAC-0001(Tanibirumab) in Recurrent Glioblastoma

Pembrolizumab +/- Bevacizumab for Recurrent GBM

Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors

Biologically-based Target Volumes to Treat Newly Diagnosed Glioblastoma

Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma

Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma

Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification

Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas

Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma

TH-302 in Combination With Bevacizumab for Glioblastoma

A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma

Ceritinib Rare Indications Study in ALK+ Tumors

A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors

Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma

Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma

Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma

Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamic Effects of PQR309 in Glioblastoma Patients

Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma

Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma

Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients

Preliminary Assessment of [18F] Fluciclatide (GE [18F]AH111585) in Glioblastoma Multiforme Treated With Bevacizumab

NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse

Neoadjuvant Nivolumab in Glioblastoma

Efficacy and Safety of G-202 in PSMA-Positive Glioblastoma

Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma

More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery

EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma

A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2

Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM

ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma

Phase I Study of APX005M in Pediatric Central Nervous System Tumors

A Phase I First-in-human Trial of Bvax (B-cell Vaccination) in Addition to Standard of Care Chemoradiotherapy for Newly Diagnosed Glioblastoma

Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression

Surgical Nivolumab And Ipilimumab For Recurrent GBM

Phase I Trial of pH Resections of GBM at VA

WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases

Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells

Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma

A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.

Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma

Pilot Study of Navigated Focused Ultrasound and Pembrolizumab in the Treatment of Recurrent WHO Grade 4 IDH-Wildtype Glioblastoma With Mismatch Repair Deficiency

CARv3-TEAM-E T Cells in Glioblastoma

Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma

CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma

GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma

Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM

Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma

A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma

131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2)

Study of Low-Intensity Focused Ultrasound in Combination With Immunotherapy in Newly Diagnosed Unmethylated Glioblastoma

Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma

Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma

Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer

A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)

IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma

RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)

A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas

Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.

Different Approaches for CART-EGFR-IL13Ra2 Dosing in Recurrent GBM

Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma

OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma

A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma

ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or Astrocytoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial

B7H3/IL13Ra2 Bispecific Armored Chimeric Antigen Receptor T-Cell Therapy Study for Recurrent/Refractory Glioblastoma

Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas

A Study of 177Lu-PSMA-617 in People With Gliomas

BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma

Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma

Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma

Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy

D2C7-IT + 2141-V11 Combination Post-resection in rGBM

Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas

Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc

Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma

Ketogenic Diet in Combination With Standard-of-care Radiation and Temozolomide for Patients With Glioblastoma

Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma

CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM

Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma

CUE-102 in Recurrent Glioblastoma

A Phase 1 Study of the Safety and Tolerability of MT-125 in GBM Patients

RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma

Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy

Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic Brachytherapy

MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM

Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma

Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma

A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma

A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment.

A Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)

Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas

PH Sensitive MRI Based Resections of Glioblastoma

ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma

A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma

Trial of C134 in Patients With Recurrent GBM

CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy

A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)

IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM

BC008-1A Injection for Recurrent CNS WHO G4 Glioma

Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma

Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma

Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma

Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma

Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors

A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma

Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults

5G-EMERALD: Amivantamab in Malignant Brain Tumours

First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours

A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM)

Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma

Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery

A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in Recurrent Glioblastoma

Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme

Sonodynamic Therapy in Patients With Recurrent GBM

Study to Evaluate the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of ITI-1001 In Patients With Newly Diagnosed Glioblastoma (GBM)

Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With Glioblastoma

Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma

Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma

Phase 1 Open-label Study of 123I-ATT001 in Subjects with Relapsed Glioblastoma

The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM

CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM)

Targeted Survivin DC Cell Injection for the Treatment of GBM

Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma

Tris-CAR-T Cell Therapy for Recurrent Glioblastoma

Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma

Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma

Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac®

A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma

Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)

Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma

Safety and Tolerability of CVGBM in Adults With Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma

Feasibility of Individualized Therapy for Recurrent Glioblastoma

Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1)

Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients

INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas

Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma

A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.

Multi-kinase Inhibitor TG02 (TG02) in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma.

Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status)

Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer

Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma

ASP8374 + Cemiplimab in Recurrent Glioma

A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer

Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma

Chlorpromazine and Standard of Care in Glioblastoma

Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102

A Study to Determine How BI 907828 (Brigimadlin) is Taken up in the Tumor (Phase 0) and to Determine the Highest Dose of BI 907828 (Brigimadlin) That Could be Tolerated (Phase 1a) in Combination With Radiation Therapy in People With a Brain Tumor Called Glioblastoma

A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102

RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients.

A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma

Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma

A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM

A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma

Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas

A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma

Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)

Phase I EGFR BATs in Newly Diagnosed Glioblastoma

Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine

A Study of Intra-tumoral Administered MTX110 in Patients With Recurrent Glioblastoma

A Study to Investigate 14C-bemcentinib in Healthy Male Subjects

Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma

Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas

Multi Peptide Vaccination with XS15 in Addition to Standard Postoperative Radiation Therapy and Temozolomide Chemotherapy in Newly Diagnosed Glioblastoma

NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma

Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma

Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma

Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with Glioblastoma

[18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers

A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed Glioblastoma

Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade

CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma

A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors

Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors

Feasibility Study on LITT for Newly Diagnosed Glioblastoma

Cancer Stem Cell High-Throughput Drug Screening Study

Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children

Safety and Efficacy of Different Administration Sequences of L19TNF With Lomustine in Glioblastoma at First Progression

Reirradiation and Niraparib in Patients With Recurrent Glioblastoma

Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM

A Dose Escalation Phase I Study Of Human- Recombinant Bone Morphogenetic Protein 4 Administrated Via CED In GBM Patients

HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors

Dendritic Cell Vaccination With Standard Postoperative Chemoradiation for the Treatment of Adult Glioblastoma

Radiation Therapy With Temozolomide and Pembrolizumab in Treating Patients With Newly Diagnosed Glioblastoma

A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies

Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma

Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas

Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)

INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme

Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection

mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma Multiforme

Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors

CART-EGFRvIII + Pembrolizumab in GBM

Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2

Monocyte Antigen Carrier Cells for Newly Diagnosed GBM

Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors

Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma

DNX-2440 Oncolytic Adenovirus for Recurrent Glioblastoma

Sulfasalazine and Stereotactic Radiosurgery for Recurrent Glioblastoma

A Study to Evaluate the Safety of LAM561 Added to Standard of Care in Newly-diagnosed Glioblastoma Patients

EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma

Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma

A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)

Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

Study of Icapamespib (PU-AD) in Patients With Recurrent Malignant Glioma

A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma

Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM

A Phase I Clinical Trial of Bevacizumab Injection

Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors

Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens

Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2)

Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC)

RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas

STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain

Avelumab With Laser Interstitial Therapy for Recurrent Glioblastoma

[18F]Fluciclovine in Post-treatment Glioblastoma ( Axumin )

A Trial of KB004 in Patients With Glioblastoma

Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma

BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab

ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma

Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer

Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM

Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma

Doxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade Gliomas

Dose-escalation Study to Evaluate the Safety and Tolerability of GX-I7 in Patients With Glioblastoma

NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors

Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of Glioblastoma

Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors

Nivolumab With DC Vaccines for Recurrent Brain Tumors

Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment

The Addition of Chloroquine to Chemoradiation for Glioblastoma

Enhancing Optune Therapy With Targeted Craniectomy

A Phase I Study of Immunotherapy With GSC -Loaded Dendritic Cells in Patients With Recurrent Glioblastoma

Pre-operative RT and TMZ in Patients With Newly Diagnosed GBM Diagnosed Glioblastoma. A Phase I Study. (PARADIGMA)

Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma

Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

A Study of CAN008 for Newly Diagnosed Glioblastoma Multiforme

Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma

VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma

Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma

A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor

Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed Glioblastoma

Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma

Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma

Dose-Escalation Study of Carboplatin Administration Into the Brain for Glioblastoma Multiforme

Pediatric Long-Term Follow-up and Rollover Study

GammaTile and Stupp in Newly Diagnosed GBM

The Assessment of Immune Response in Newly Diagnosed Glioblastoma Patients Treated With Pembrolizumab

Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy

Post-operative Adjuvant Therapy w/wo GammaTile + Systemic Therapy